Active Shortage Injection Anesthesia
Rocuronium Bromide Injection · 1,304 days since initial FDA posting
Brand: ROCURONIUM BROMIDE
FDA lists Rocuronium Bromide Injection as Active Shortage (XGen Pharmaceuticals DJB, Inc.).
Availability on file: Available
Rocuronium Bromide Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Rocuronium Bromide Injection
- Manufacturer
- XGen Pharmaceuticals DJB, Inc.
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)
- Package NDC
- 39822-4200-2
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Feb 15, 2023
- Last Updated
- Jan 8, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Rocuronium Shortage Records
Rocuronium Bromide Injection
Piramal Critical Care Inc.
Injection
Rocuronium Bromide Injection
Piramal Critical Care Inc.
Injection
Rocuronium Bromide Injection
Meitheal Pharmaceuticals, Inc.
Injection
Rocuronium Bromide Injection
Meitheal Pharmaceuticals, Inc.
Injection
Rocuronium Bromide Injection
Sandoz Inc.
Injection
Rocuronium Bromide Injection
Sandoz Inc.
Injection